OBJECTIVE: Systemic lupus erythematosus is a clinically heterogeneous autoimmune disease. A number of genetic loci that increase lupus susceptibility have been established. This study examines if these genetic loci also contribute to the clinical heterogeneity in lupus. MATERIALS AND METHODS: 4001 European-derived, 1547 Hispanic, 1590 African-American and 1191 Asian lupus patients were genotyped for 16 confirmed lupus susceptibility loci. Ancestry informative markers were genotyped to calculate and adjust for admixture. The association between the risk allele in each locus was determined and compared in patients with and without the various clinical manifestations included in the ACR criteria. RESULTS: Renal disorder was significantly correlated with the lupus risk allele in ITGAM (p=5.0 × 10(-6), OR 1.25, 95% CI 1.12 to 1.35) and in TNFSF4 (p=0.0013, OR 1.14, 95% CI 1.07 to 1.25). Other significant findings include the association between risk alleles in FCGR2A and malar rash (p=0.0031, OR 1.11, 95% CI 1.17 to 1.33), ITGAM and discoid rash (p=0.0020, OR 1.20, 95% CI 1.06 to 1.33), STAT4 and protection from oral ulcers (p=0.0027, OR 0.89, 95% CI 0.83 to 0.96) and IL21 and haematological disorder (p=0.0027, OR 1.13, 95% CI 1.04 to 1.22). All these associations are significant with a false discovery rate of <0.05 and pass the significance threshold using Bonferroni correction for multiple testing. CONCLUSION: Signifi cant associations were found between clinical manifestations and the FCGR2A, ITGAM, STAT4, TNSF4 and IL21 genes. The findings suggest that genetic profiling might be a useful tool to predict disease manifestations in lupus patients in the future.
OBJECTIVE:Systemic lupus erythematosus is a clinically heterogeneous autoimmune disease. A number of genetic loci that increase lupus susceptibility have been established. This study examines if these genetic loci also contribute to the clinical heterogeneity in lupus. MATERIALS AND METHODS: 4001 European-derived, 1547 Hispanic, 1590 African-American and 1191 Asian lupus patients were genotyped for 16 confirmed lupus susceptibility loci. Ancestry informative markers were genotyped to calculate and adjust for admixture. The association between the risk allele in each locus was determined and compared in patients with and without the various clinical manifestations included in the ACR criteria. RESULTS:Renal disorder was significantly correlated with the lupus risk allele in ITGAM (p=5.0 × 10(-6), OR 1.25, 95% CI 1.12 to 1.35) and in TNFSF4 (p=0.0013, OR 1.14, 95% CI 1.07 to 1.25). Other significant findings include the association between risk alleles in FCGR2A and malar rash (p=0.0031, OR 1.11, 95% CI 1.17 to 1.33), ITGAM and discoid rash (p=0.0020, OR 1.20, 95% CI 1.06 to 1.33), STAT4 and protection from oral ulcers (p=0.0027, OR 0.89, 95% CI 0.83 to 0.96) and IL21 and haematological disorder (p=0.0027, OR 1.13, 95% CI 1.04 to 1.22). All these associations are significant with a false discovery rate of <0.05 and pass the significance threshold using Bonferroni correction for multiple testing. CONCLUSION: Signifi cant associations were found between clinical manifestations and the FCGR2A, ITGAM, STAT4, TNSF4 and IL21 genes. The findings suggest that genetic profiling might be a useful tool to predict disease manifestations in lupus patients in the future.
Authors: Elena Sanchez; Ryan D Webb; Astrid Rasmussen; Jennifer A Kelly; Laura Riba; Kenneth M Kaufman; Ignacio Garcia-de la Torre; Jose F Moctezuma; Marco A Maradiaga-Ceceña; Mario H Cardiel-Rios; Eduardo Acevedo; Mariano Cucho-Venegas; Mercedes A Garcia; Susana Gamron; Bernardo A Pons-Estel; Carlos Vasconcelos; Javier Martin; Teresa Tusié-Luna; John B Harley; Bruce Richardson; Amr H Sawalha; Marta E Alarcón-Riquelme Journal: Arthritis Rheum Date: 2010-12
Authors: C Tanasescu; E Balanescu; P Balanescu; R Olteanu; C Badea; C Grancea; C Vagu; C Bleotu; C Ardeleanu; A Georgescu Journal: Eur J Intern Med Date: 2010-04-08 Impact factor: 4.487
Authors: Xana Kim-Howard; Amit K Maiti; Juan-Manuel Anaya; Gail R Bruner; Elizabeth Brown; Joan T Merrill; Jeffrey C Edberg; Michelle A Petri; John D Reveille; Rosalind Ramsey-Goldman; Graciela S Alarcon; Timothy J Vyse; Gary Gilkeson; Robert P Kimberly; Judith A James; Joel M Guthridge; John B Harley; Swapan K Nath Journal: Ann Rheum Dis Date: 2009-11-25 Impact factor: 19.103
Authors: A-K Abelson; A M Delgado-Vega; S V Kozyrev; E Sánchez; R Velázquez-Cruz; N Eriksson; J Wojcik; M V P Linga Reddy; G Lima; S D'Alfonso; S Migliaresi; V Baca; L Orozco; T Witte; N Ortego-Centeno; H Abderrahim; B A Pons-Estel; C Gutiérrez; A Suárez; M F González-Escribano; J Martin; M E Alarcón-Riquelme Journal: Ann Rheum Dis Date: 2008-11-19 Impact factor: 19.103
Authors: Wanling Yang; Minghui Zhao; Nattiya Hirankarn; Chak Sing Lau; Chi Chiu Mok; Tak Mao Chan; Raymond W S Wong; Ka Wing Lee; Mo Yin Mok; Sik Nin Wong; Yingyos Avihingsanon; Irene Oi Lin; Tsz Leung Lee; Marco Hok Kung Ho; Pamela Pui Wah Lee; Wilfred Hing Sang Wong; Pak Chung Sham; Yu Lung Lau Journal: Hum Mol Genet Date: 2009-03-13 Impact factor: 6.150
Authors: Amr H Sawalha; Lu Wang; Ajay Nadig; Emily C Somers; W Joseph McCune; Travis Hughes; Joan T Merrill; R Hal Scofield; Faith M Strickland; Bruce Richardson Journal: J Autoimmun Date: 2012-02-03 Impact factor: 7.094